Intrahepatic cholostasis following combined diazepam-barbiturate therapy in patients with tetanus.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002746:Chlorpromazine / Q000009:adverse effects; D002779:Cholestasis / Q000097:blood / Q000139:chemically induced*; D003975:Diazepam / Q000009:adverse effects*; D004338:Drug Combinations; D005260:Female; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D010424:Pentobarbital / Q000009:adverse effects*; D010634:Phenobarbital / Q000009:adverse effects*; D013742:Tetanus / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D010424:Pentobarbital; D003975:Diazepam; D002746:Chlorpromazine; D010634:Phenobarbital
Intrahepatische Cholestase nach einer hochdosierten Kombinationstherapie mit Diazepam und Barbituraten bei Tetanus-Patienten.